Evidence map›Paper›PMID 41751850›Full record

ReviewInternational journal of molecular sciences2026

Decoding the Role of Lipid Metabolism and Membrane Dynamics in Melanoma.

Maria Elena Pisanu, Egidio Iorio, Francesco Facchiano, Mattea Chirico, Maria Luisa Scattoni, Claudio Tabolacci

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Elena PisanuCore Facilities, High Resolution NMR Unit, Istituto Superiore di Sanità, 00161 Rome, Italy.
Egidio IorioCore Facilities, High Resolution NMR Unit, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0001-6673-3838
Francesco FacchianoDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0003-4313-0617
Mattea ChiricoCore Facilities, High Resolution NMR Unit, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0002-3447-5077
Maria Luisa ScattoniCoordination and Promotion of Research, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.ORCID 0000-0002-6659-0280
Claudio TabolacciCoordination and Promotion of Research, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.ORCID 0000-0001-5001-285X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous melanoma is a highly aggressive type of cancer with a poor prognosis at advanced stages. Accumulating evidence demonstrates that metabolic reprogramming is essential for melanoma, allowing it to adapt to both cellular changes, due to its genetic instability, and to micro-environmental stimuli. This review provides an overview of how melanoma cells remodel membrane lipids during melanoma progression with a focus on how environmental stresses (e.g., UV radiation) affect tumor aggressiveness and therapy resistance by reshaping membrane structure, fluidity, and composition. Dietary lipids, especially omega-3 polyunsaturated fatty acids (PUFAs), further modulate membrane properties and can sensitize melanoma cells to oxidative stress and ferroptosis, revealing potential therapeutic vulnerabilities. Finally, we discuss emerging evidence that lipid signatures, including circulating lipid profiles and melanoma-derived exosomes, have prognostic and predictive value. Together, these insights emphasize the importance of lipid metabolism and membrane architecture as key factors in melanoma biology and as promising targets for personalized interventions.

Indexed as

Cell MembraneLipid MetabolismMelanomaMembrane LipidsSkin NeoplasmsAnimalsHumansMetabolic ReprogrammingOxidative StressMembrane Lipidsdietlipid metabolismmelanomamembraneUV radiation

Identifiers

PMID41751850
PMCPMC12940636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.